PrimeC and ibudilast

Status
Not open for further replies.

lgelb

Moderator
Forum Supporter
Joined
Nov 5, 2009
Messages
14,973
Reason
Lost a loved one
Diagnosis
00/0000
Country
US
State
WA
City
Seattle
Cipro and Celebrex, the brand names for the compounds in PrimeC, both have cousins that were withdrawn from the market (Tequin and Vioxx, respectively) and black box warnings for events such as tendon rupture and heart attacks, respectively. Neither is considered first line therapy any longer in their indications. Both are in unmarketed (proprietary) dosages for the PrimeC product in trial.

In addition to trial exclusions for a boatload of heart, kidney, and GI conditions, there is also a seizure potential warning against combining the two.

The phase 2 ibudilast trial results were negative. By torturing some secondary endpoints, and building a mechanistic argument, armed with a riluzole combo patent, funding is flowing for late-stage trials, but results are far from assured. 86% of PALS had at least one suspect adverse event, 37% had to reduce the dose, and a third discontinued early due to adverse events. There is also a case report with various combos, describing blood pressure and vision changes.

As with most therapies, there may be a sweet spot PALS for whom it works great. If you do a DIY trial to find out if you're one of them and it turns out you're not, please be prepared to act on that result. Some of us are old enough to remember when gabapentin, minocycline, lithium, and creatine were the hottest things going in ALS. None was worth the risks, and some PALS did get worse instead.

If you want to try more interventions, I would direct you to the trials on tap and the long list of things that do have proven benefit, and that are often underutilized.

These include BiPAP, feeding tubes, real food blending, positioning (hospital beds with reverse Trendelenburg positioning, lift chairs, foam blocks/boots, temperature-controlled bedding, latex pillows/overlays) and mobility devices (wheelchairs, patient lifts) along with judicious use of meds, suction, oscillation, assisted cough, etc. And Internet/mobile technology/assistive devices for communication, content creation/consumption, and social interaction.

We know these affect quantity and quality of life. We don't have that level of evidence for the pipeline meds. It's always your choice to DIY, but it's also exclusively your risk.
 
Last edited:
Agree with Laurie. I am FALS as many of you know. I have seen a lot of what Laurie describes in PALS I have known

My own sister took multiple things offlabel that were in trial and even did a kind of expanded access for a medication that was in phase 3 and considered very promising and sure to be successful and approved ( think relyvrio if it had not received approval after phase 2 and we were waiting for phase 3). In spite of a REALLY promising phase 2 it failed phase 3. Of course my sister stopped it and told me later she thought it accelerated her progression but she couldn’t tell because she had started it early in her diagnosis

Another example of a promising drug making people worse- the C9 version of Qalsody. and this was a drug with a mechanism proven in other genetic diseases and tailored specifically to the pathology of the recipients
 
Hi,
I´m on off label "PrimeC" so I have a lot of thoughts on this. Ultimately, as you said, its our own risk so hopefully anyone interested finds a good doctor able to discuss the risk evaluation.
Lgelb, you mentioned "There is also a seizure potential warning against combining the two", where does this come from? From the trial documentation?
 

Also "Known or suspected diagnosis or family history of epilepsy" is an exclusion criterion in the trials.
 
Last edited:
  • Like
Reactions: JAM
There is an article today regarding Prime C in ALS NewsToday. It seems very promising! So great to give even some hope♥️
 
I understand that you are trying to get as much information as possible. Please read critically especially on that site. When they present research look for the primary source to get really accurate information. I think you refer to Prime C getting a patent ? That is good for the company but doesn’t mean a lot to us. You will also see a lot of big pharma press releases. Remember they are geared toward their investors and try very hard to paint a rosy picture. I saw one recently touting the fact that their trial participants had stable nfls while on drug. Stable ( but elevated ) nfl is usual for pals so unremarkable and elevated nfl means ongoing neurodegeneration.

I really am not trying to be negative though it may sound like it. Navigating the ALS landscape is difficult especially when you do not have a supportive neuro
 
I appreciate you explaining that to me. I had no idea😞. I guess it may not be as good news as I thought.
 
It isn’t bad news. Just neutral
 
  • Like
Reactions: JAM
I would add learn to read papers especially trial results. If you are not used to them it might be hard at first but gradually you will get used to it. Bench research is good too. Always remember though that a promising result in mice or petri dishes does not mean it will help us. At best it will take time to come to trial let alone to market
 
I have read some trial results and you’re correct- it’s confusing! I’ll keep trying though. I enjoy learning, so there’s that ☺️.
 
You might find the webinars the healey center does helpful. They were originally just to update on the platform trial but they have branched out a bit Thursdays at 5 pm most weeks and they are recorded so you can listen to older ones

Also look at the neals consortium sites. They do webinars on various topics sometimes for trials, sometimes topics of interest for the community. They are always recorded and archived. I

Les turner foundation also has webinars mostly on navigating als and they are archived

Ccals has webinars too
 
What about Dr. Bedlack? I just watched one of his videos. Wow! He is so kind and seems to genuinely care. I wish we had a Dr. more like him. I’m sure our Dr. cares I don't mean to imply he doesn’t.
 
I like Dr Bedlack personally. I have interacted with him a little and he has been kind. He is kind of a niche resource. His two big projects are his reversals studies and alsuntangled. The latter is a good resource if you are considering supplements or other non standard treatments. The reversals study is interesting and he has done some studies of a few of the treatments used. All have failed so far and now it seems the reversals may actually have a protective genetic variant. All this is great as is the fact he gives time to speak to various topics.

However the resources I have suggested have a lot of information that I think you will benefit from as well

I believe you are seeking a second opinion? I hope that doctor is a better fit
 
  • Like
Reactions: JAM
Bedlack is remarkable!!
 
  • Like
Reactions: JAM
Status
Not open for further replies.
Back
Top